

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.


(Sharecast News) - hVIVO announced on Tuesday that it has secured its largest standalone laboratory contract to date, with its hLAB division signing a...


(Alliance News) - hVIVO PLC on Tuesday said subsidiary hLAB has signed its "largest contract to date" with an unnamed US-based biotechnology client.


(Sharecast News) - Contract research organisation and human challenge trial specialist hVIVO announced the successful completion of a pilot characteri...


(Sharecast News) - Contract research organisation Hvivo has struck a £11.5m Respiratory Syncytial Virus contract with an "existing top-tier globa...


(Sharecast News) - Specialist contract research organisation hVIVO announced positive results from a phase 2a human challenge trial (HCT) for Enanta P...


(Sharecast News) - Specialist contract research organisation hVIVO launched the full suite of services provided by its hLAB division - a highly specia...


(Alliance News) - hVIVO PLC on Tuesday said profit for its interim results had risen more than 70%, as an "exceptionally strong" first half brought ab...